Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions

Biochemical and Biophysical Research Communications

Volumn 313, Issue 4, 2004, Pages 954-961

  Cho, Jae Youl ^a,b   Kim, Ae Ra ^c   Joo, Hong Gu ^d   Kim, Byung Hun ^e   Rhee, Man Hee ^f   Yoo, Eun Sook ^g   Katz, David R ^b   Chain, Benjamin M ^b   Jung, Jee H ^c  

^a Kangwon National University   (South Korea)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Pusan National University   (South Korea)

^d Jeju National University   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Kyungpook National University   (South Korea)

^g Jeju National University School of Medicine   (South Korea)

Author keywords

Adhesion molecule; CD147; CD29 ( 1 integrins); CD98; Cynaropicrin; ERK; Homotypic aggregation; Sesquiterpene lactone

Indexed keywords

BETA1 INTEGRIN; CD147 ANTIGEN; CD98 ANTIGEN; CELL ADHESION MOLECULE; CHLOROQUINE; CYNAROPICRIN; CYTOCHALASIN B; FORSKOLIN; LEUKOSIALIN; MITOGEN ACTIVATED PROTEIN KINASE; PROPRANOLOL; ROTTLERIN; SESQUITERPENE LACTONE DERIVATIVE;

ANTIGEN FUNCTION; ARTICLE; CELL ADHESION; CELL AGGREGATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IC 50; IMMUNOMODULATION; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0346728753     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.026     Document Type: Article

References (42)

1. Robles M., Aregullin M., West J., Rodriguez E. Recent studies on the zoopharmacognosy, pharmacology, and neurotoxicology of sesquiterpene lactone. Planta Med. 61:1995;199-203.
2. Taniguchi M., Kataoka T., Suzuki H., Uramoto M., Ando M., Arao K., Magae J., Nishimura T., Otake N., Nagai K. Costunolide and dehydrocostus lactone as inhibitors of killing function of cytotoxic T lymphocytes. Biosci. Biotechnol. Biochem. 59:1995;2064-2067.
3. Park H.J., Kwon S.H., Han Y.N., Choi J.W., Miyamoto K., Lee S.H., Lee K.T. Apoptosis-inducing costunolide and a novel acyclic monoterpene from the stem bark of Magnolia sieboldii. Arch. Pharm. Res. 24:2001;342-348.
4. Wen J., You K.R., Lee S.Y., Song C.H., Kim D.G. Oxidative stress-mediated apoptosis: the anticancer effect of the sesquiterpene lactone parthenolide. J. Biol. Chem. 277:2002;38954-38964.
5. Hwang D., Fischer N.H., Jang B.C., Tak H., Kim J.K., Lee W. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem. Biophy. Res. Commun. 226:1996;810-818.
6. Bork P.M., Schmitz M.L., Kuhnt M., Escher C., Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB. FEBS Lett. 402:1997;85-90.
7. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Droge W., Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β J. Biol. Chem. 272:1998;135-143.
8. Cho J.Y., Park J., Yoo E.S., Baik K.U., Lee J., Park M.H. Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-α production in murine macrophage-like cell. Planta Med. 64:1998;594-597.
9. Jung J.H., Ha J.Y., Min K.R., Shibata F., Nakagawa H., Kang S.S., Chang I.M., Kim Y. Reynosin from Saussurea lappa as inhibitor on CINC-1 induction in LPS-stimulated NRK-52E cells. Planta Med. 64:1998;454-455.
10. Cho J.Y., Baik K.U., Jung J.H., Park M.H. In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur. J. Pharmacol. 398:2000;399-407.
11. Holly S.P., Larson M.K., Parise L.V. Multiple roles of integrins in cell motility. Exp. Cell Res. 261:2000;69-74.
12. Muller W.A. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24:2003;327-334.
13. Yang G.X., Hagmann W.K. VLA-4 antagonists: potent inhibitors of lymphocyte migration. Med. Res. Rev. 23:2003;369-392.
14. Fuggle S.V., Koo D.D. Cell adhesion molecules in clinical renal transplantation. Transplantation. 65:1998;763-769.
15. Whitcup S.M., Chan C.C., Kozhich A.T., Magone M.T. Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis. Clin. Immunol. 93:1999;107-113.
16. S. Hong, S.H. Kim, M.H. Rhee, A.R. Kim, J.H. Jung, T. Chun, E.S. Yoo, J.Y. Cho, In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges, Naunyn Schmiedebergs Arch. Pharmacol. (2003), in press.
17. Cho J.Y., Fox D.A., Horejsi V., Sagawa K., Skubitz K.M., Katz D.R., Chain B. The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood. 98:2001;374-382.
18. Cho J.Y., Chain B.M., Vives J., Horejsi V., Katz D.R. Regulation of CD43-induced U937 homotypic aggregation. Exp. Cell Res. 290:2003;155-167.
19. Cho J.Y., Skubitz K.M., Katz D.R., Chain B.M. CD98-dependent homotypic aggregation is associated with translocation of protein kinase Cdelta and activation of mitogen-activated protein kinases. Exp. Cell Res. 286:2003;1-11.
20. J.Y. Cho, J.S. Park, K.U. Baik, J.G. Lee, H.P. Kim, E.S. Yoo, M.H. Park, Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevant to rheumatoid arthritis. Pharmacol. Res. (2003), in press.
21. Cho J.Y., Yoo E.S., Baik K.U., Park M.H., Han B.H. In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists. Planta Med. 67:2001;213-218.
22. Cho J.Y., Katz D.R., Chain B.M. Staurosporine induces rapid homotypic intercellular adhesion of U937 cells via multiple kinase activation. Br. J. Pharmacol. 140:2003;269-276.
23. Miyamoto Y.J., Andruss B.F., Mitchell J.S., Billard M.J., McIntyre B.W. Diverse roles of integrins in human T lymphocyte biology. Immunol. Res. 27:2003;71-84.
24. Khunkeawla P., Moonsom S., Staffler G., Kongtawelert P., Kasinrerk W. Engagement of CD147 molecule-induced cell aggregation through the activation of protein kinases and reorganization of the cytoskeleton. Immunobiology. 203:2001;659-669.
25. Feldhaus M.J., Weyrich A.S., Zimmerman G.A., McIntyre T.M. Ceramide generation in situ alters leukocyte cytoskeletal organization and beta 2-integrin function and causes complete degranulation. J. Biol. Chem. 277:2002;4285-4293.
26. Roma M.G., Stone V., Shaw R., Coleman R. Vasopressin-induced disruption of actin cytoskeletal organization and canalicular function in isolated rat hepatocyte couplets: possible involvement of protein kinase C. Hepatology. 28:1998;1031-1041.
27. Glenn H.L., Jacobson B.S. Cyclooxygenase and cAMP-dependent protein kinase reorganize the actin cytoskeleton for motility in HeLa cells. Cell Motil. Cytoskeleton. 55:2003;265-277.
28. Diaz L.A. Jr., Friedman A.W., He X., Kuick R.D., Hanash S.M., Fox D.A. Monocyte-dependent regulation of T lymphocyte activation through CD98. Int. Immunol. 9:1997;1221-1231.
29. Stonehouse T.J., Woodhead V.E., Herridge P.S., Ashrafian H., George M., Chain B.M., Katz D.R. Molecular characterization of U937-dependent T-cell co-stimulation. Immunology. 96:1999;35-47.
30. Woodhead V.E., Stonehouse T.J., Binks M.H., Speidel K., Fox D.A., Gaya A., Hardie D., Henniker A.J., Horejsi V., Sagawa K., Skubitz K.M., Taskov H., Todd III R.F., van Agthoven A., Katz D.R., Chain B.M. Novel molecular mechanisms of dendritic cell-induced T cell activation. Int. Immunol. 12:2000;1051-1061.
31. Warren A.P., Patel K., McConkey D.J., Palacios R. CD98: a type II transmembrane glycoprotein expressed from the beginning of primitive and definitive hematopoiesis may play a critical role in the development of hematopoietic cells. Blood. 87:1996;3676-3687.
32. Tsurudome M., Ito Y. Function of fusion regulatory proteins (FRPs) in immune cells and virus-infected cells. Crit. Rev. Immunol. 20:2000;167-196.
33. Fenczik C.A., Sethi T., Ramos J.W., Hughes P.E., Ginsberg M.H. Complementation of dominant suppression implicates CD98 in integrin activation. Nature. 390:1997;81-85.
34. Petty H.R., Worth R.G., Todd III R.F. Interactions of integrins with their partner proteins in leukocyte membranes. Immunol. Res. 25:2002;75-95.
35. Lasky L.A. How integrins are activated. Nature. 390:1997;15-17.
36. K. Mori, M. Nishimura, M. Tsurudome, M. Ito, M. Nishio, M. Kawano, Y. Kozuka, Y. Yamashita, H. Komada, A. Uchida, Y. Ito, The functional interaction between CD98 and CD147 in regulation of virus-induced cell fusion and osteoclast formation. Med. Microbiol. Immunol. (Berl) (2003), in press.
37. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell. 110:2002;673-687.
38. Kakugawa K., Hattori M., Beauchemin N., Minato N. Activation of CEA-CAM-1-mediated cell adhesion via CD98: involvement of PKCdelta. FEBS Lett. 552:2003;184-188.
39. Ku H., Meier K.E. Phosphorylation of paxillin via the ERK mitogen-activated protein kinase cascade in EL4 thymoma cells. J. Biol. Chem. 275:2000;11333-11340.
40. Liu F., Verin A.D., Borbiev T., Garcia J.G. Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L1309-L1317.
41. Ashida N., Arai H., Yamasaki M., Kita T. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J. Biol. Chem. 276:2001;16555-16560.
42. Reyes-Reyes M., Mora N., Gonzalez G., Rosales C. beta1 and beta2 integrins activate different signalling pathways in monocytes. Biochem. J. 363:2002;273-280.